- Poster presentation
- Open Access
Plasma levels of IL-6 and IL-10 in septic patients at admission and during follow-up and association with clinical outcomes
Critical Care volume 15, Article number: P19 (2011)
Sepsis is a systemic inflammatory syndrome triggered by infection. It has been recognized that a dynamic interaction between proinflammatory and anti-inflammatory response is present in this syndrome, which is balanced by as yet unknown mechanisms. We and others showed that inflammatory cytokines are upregulated in the early phase and downregulated in the late phases of sepsis, while anti-inflammatory cytokines are preserved. However, there are few data about the dynamics of these cytokines during follow-up of patients and their relation with clinical outcome. The aim of this study was to evaluate the plasma levels of a proinflammatory, IL-6, and an anti-inflammatory, IL-10, cytokine in septic patients.
This prospective study included 53 septic patients (SP) and 29 healthy volunteers (HV) as a control group. Patients were admitted to the intensive care units of São Paulo, Sirio-Libanes and Israelita Albert Einstein hospitals. Samples were collected during the first 48 hours of organ dysfunction or sepsis (D0). A second sample was collected after 7 days from 35 SP (D7). The plasma levels of cytokines were measured using the cytometric bead array method (limit detection 2.0 pg/ml) by flow cytometry.
IL-6 and IL-10 plasma levels were higher in SP (median 170.8 pg/ml, range 3.53 to 16,028.52 pg/ml; and median 6.6 pg/ml, range 0.0 to 1,698.92 pg/ml, respectively) than HV (median 2.3 pg/ml, range 0.0 to 19.92 pg/ml for IL-6; and median 2.4 pg/ml, range 0.0 to 12.7 pg/ml for IL-10) (P = 0.0001 and P = 0.007, respectively). Plasma levels of IL-6 and IL-10 at D7 were not significant different from those at D0 (P = 0.85 and P = 0.59, respectively). IL-6 and IL-10 admission plasma levels were higher in nonsurvivors (median 284.76 pg/ml, range 9.16 to 16,028.52 pg/ml; and median 17.6 pg/ml, range 0.0 to 1,698.92 pg/ml, respectively) than in survivors (median 103.57, range 3.53 to 9,745.43 pg/ml; and median 9.91 pg/ml, range 0.0 to 313 pg/ml; P = 0.02 and P = 0.003, respectively).
Our results show that both proinflammatory and anti-inflammatory cytokines are detected during sepsis and a higher level of both cytokines at admission is associated with worst outcomes.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Costa, R., Brunialti, M., Machado, F. et al. Plasma levels of IL-6 and IL-10 in septic patients at admission and during follow-up and association with clinical outcomes. Crit Care 15 (Suppl 2), P19 (2011). https://doi.org/10.1186/cc10167
- Intensive Care Unit
- Healthy Volunteer
- Plasma Level
- Inflammatory Cytokine
- Late Phase